UPDATE 1-Strong U.S. sales boost Valeant Pharma profit, revenue

April 29 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc's quarterly profit and revenue beat market estimates, helped by a 39 percent jump in U.S. sales.